CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population

Ho Cheol Kim, Wonjun Ji, Jae Cheol Lee, Hyeong Ryul Kim, Si Yeol Song, Chang-Min Choi, ,

Cancer Research and Treatment. 2021;53(4):1033-1041. Published online 2021 February 16 DOI: https://doi.org/10.4143/crt.2020.1350

Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population

Ho Cheol Kim, Wonjun Ji, Jae Cheol Lee, Hyeong Ryul Kim, Si Yeol Song, Chang-Min Choi, ,

Cancer Research and Treatment. 2021;53(4):1033-1041

Link1

Link2 Link3

Tumor Volume is a Better Prognostic Factor than Greatest Tumor Diameter in operated Stage I-III Non-small Cell Lung Cancer

Ayşe Ocak Duran, Mevlude Inanc, Oktay Bozkurt, Ersin Ozaslan, Metin Ozkan

Clinical Lung Cancer. 2023;

Link1 Link2

Real-world data of using durvalumab in stage III non-small cell lung cancer (NSCLC): West Midlands experience

A. Jegannathen

Lung Cancer. 2020;139:S51

Link1 Link2

Improving Outcomes for High-Risk Patients With Early-Stage Non–Small-Cell Lung Cancer: Insights from Population-Based Data and the Role of Stereotactic Ablative Radiotherapy

David A. Palma, Suresh Senan

Clinical Lung Cancer. 2013;14(1):1-5

Link1 Link2

Prognostic Factors in Stage III Non–Small-Cell Lung Cancer

Foluso O. Ademuyiwa, Cynthia S. Johnson, Angela S. White, Timothy E. Breen, Jayme Harvey, Marcus Neubauer, Nasser H. Hanna

Clinical Lung Cancer. 2007;8(8):478-482

Link1 Link2

Prophylactic Cranial Irradiation Versus Observation in Stage III Non–Small-Cell Lung Cancer

Elizabeth Gore

Clinical Lung Cancer. 2006;7(4):276-278

Link1 Link2

Commentary on “Prognostic Markers in Resected Stage I and II Non–Small-Cell Lung Cancer Patients”

David H. Harpole

Clinical Lung Cancer. 1999;1(1):68-69

Link1 Link2

Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa – KINDLE Study

A.R. Jazieh, E. Kaytan Sağlam, H.C. Önal, Y. Abdelkader, R. Gaafar, E. Dawoud, M. Nassar, D. Alshorbagy, H. El Ashry, M. Elsayed

Clinical Lung Cancer. 2022;23(4):364-373

Link1 Link2

Irinotecan Combined with Radiation Therapy for Patients with Stage III Non—Small-Cell Lung Cancer: Current Trials

Nagahiro Saijo

Clinical Lung Cancer. 2002;4:S21-S25

Link1 Link2

Application of Guideline Recommended Treatment in Routine Clinical Practice: A Population-based Study of Stage I–IIIB Non-small Cell Lung Cancer

K.J. Duggan, J. Descallar, S.K. Vinod

Clinical Oncology. 2016;28(10):639-647

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.